论文部分内容阅读
近年有人提出以托品酰胺代替阿托品作为睫状肌麻痹剂用于扩瞳验光,以避免传统验光法操作繁琐、药物作用时间过长影响患者正常工作及学习的弊端。但该药在儿童的临床应用范围尚未见报道。我科于1989年12月至1990年4月采用托品酰胺和阿托品对97例194眼屈光不正患儿进行对比验光,对托品酰胺扩瞳验光在儿童的适应范围作了初步探讨。现报道如下。对象及方法门诊就诊的屈光不正患儿97例194眼,其中男50例100眼。女47例94眼。年龄最大15岁,最小2.5岁。每个患儿先用托品酰胺(重庆医药工业研究所制)间隔5分钟滴眼一次,连续
In recent years, it was proposed to replace the atropine tropicamide as a cycloplegic agent for dilated optometry, in order to avoid the traditional optometry method cumbersome, the role of drugs for a long time affect the normal work of patients and learn the drawbacks. However, the drug in children’s clinical application has not been reported. Our department from December 1989 to April 1990 with tropicamide and atropine on 97 cases of 194 patients with refractive errors in children with a comparative optometry, the tropicamide dilation optometry in children with a preliminary study of the scope of adaptation. Report as follows now. Subjects and Methods Out-patient clinic patients with refractive errors in 97 cases 194 eyes, 50 males and 100 eyes. Female 47 cases 94 eyes. The oldest is 15 years old and the youngest is 2.5 years old. Each child with tropamide (Chongqing Institute of Pharmaceutical Industry) interval of 5 minutes eye drops once, continuous